Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leoclan CoTSE:7681 66 EV-to-FCF is 2.23 as of Aug. 03, 2026. GuruFocus rates TSE:7681 with a GF Score™ of 66/100 and a GF Value™ of 円1,290.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 72 Medical Distribution companies, Leoclan Co ranks better than 94.44% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Leoclan Co's Enterprise Value is 円3,309 Mil.
Leoclan Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,484 Mil. Therefore, Leoclan Co's EV-to-FCF for today is 2.23.
The historical rank and industry rank for Leoclan Co's EV-to-FCF or its related term are showing as below:
TSE:7681'
s EV-to-FCF Range Over the Past 10 Years
Min: -386.25 Med: -0.6 Max: 154.97
Current: 2.23
During the past 9 years, the highest EV-to-FCF of Leoclan Co was 154.97. The lowest was -386.25. And the median was -0.60.
TSE:7681's EV-to-FCF is ranked better than 94.44% of 72
companies
in the Medical Distribution industry
Industry Median: 17.395
vs TSE:7681: 2.23
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Leoclan Co's share price for today is 円955.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Leoclan Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円7.360.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Leoclan Co EV-to-FCF Related Terms
Leoclan Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Leoclan Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Leoclan Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leoclan Co EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Leoclan Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Leoclan Co's EV-to-FCF falls into.
Leoclan Co's current Enterprise Value is 円3,309 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Leoclan Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,484 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leoclan Co (TSE:7681) has a EV-to-FCF of 2.23 as of Aug. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Leoclan Co and its competitors. According to the industry distribution chart, Leoclan Co ranks #4 out of 72 companies in the Medical Distribution industry, placing it in the top 5.6%.
Is Leoclan Co's EV-to-FCF too high?
Leoclan Co's current EV-to-FCF is 2.23. The Medical Distribution industry median EV-to-FCF is 17.40. Leoclan Co's value of 2.23 is 87.2% below this industry median. Based on the distribution chart, Leoclan Co ranks #4 out of 72 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Leoclan Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Leoclan Co's EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Leoclan Co ranks #4 out of 72 companies for EV-to-FCF. This places Leoclan Co in the top 6% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 17.40. Leoclan Co's value of 2.23 is 87.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.40, based on 72 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leoclan Co's current EV-to-FCF of 2.23 is 87.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Leoclan Co and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leoclan Co's current EV-to-FCF is 2.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leoclan Co stock overvalued right now?
Based on GuruFocus' analysis, Leoclan Co (TSE:7681) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,290.91, compared to a current price of 円955.00 — trading 26% below its estimated fair value. The current EV-to-FCF is 2.23 and 87.2% below the Medical Distribution industry median of 17.40. Leoclan Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Leoclan Co (TSE:7681), the current EV-to-FCF is 2.23 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leoclan Co (TSE:7681) Overvalued in 2026?
Based on GuruFocus' analysis, Leoclan Co stock appears to be undervalued.
The current stock price of 円955.00 is trading 26% below its estimated GF Value™ of 円1,290.91.
GuruFocus considers Leoclan Co to be Modestly Undervalued.
Key valuation signals for TSE:7681:
EV-to-FCF: 2.23
GF Value™: 円1,290.91 vs. price of 円955.00 (26% below fair value)
Industry Position: 87.2% below the Medical Distribution median (#4 of 72)
No single metric tells the full story. See the TSE:7681 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7681 has been successfully added to your 
